QY Research > レポート一覧 > メディカルケア > 白血病簡易診断の世界市場レポート2024-2030

白血病簡易診断の世界市場レポート2024-2030

英文タイトル: Global Leukemia Molecular Diagnostics Market Insights, Forecast to 2030

白血病簡易診断の世界市場レポート2024-2030
  • レポートID:66601
  • 発表時期:2024-11-06
  • 訪問回数:703
  • ページ数:134
  • レポート形式:PDF
  • レポート言語:英語、日本語
  • グラフ数:141
  • レポートカテゴリ: メディカルケア

販売価格(消費税別)

販売価格(消費税別)

  •  
  • 個人版

    詳細
  • マルチユーザー版

    詳細
  • 企業版

    詳細

価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=150円。
※米ドル表示価格+10%消費税。

英語版
日本語版
英語と日本語版

価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=150円。
※米ドル表示価格+10%消費税。

shenQingYangBen

お見積

shenQingYangBen

サンプルお申込み

※ご注文方法:お問い合わせフォームまたはメールにてご連絡ください。
支払方法:「銀行振込」の場合, 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期:原則として、受注後2~4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8~10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

biaoTi

概要

本報告書は白血病簡易診断市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは白血病簡易診断の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の白血病簡易診断市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは白血病簡易診断のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に白血病簡易診断市場を分類しています。本研究に含まれる主な企業は:Ruiang Gene、Zhishan Bio、Zhijiang Bio、Jinpujia Medical、Merle Bio、Herui Gene、Aicon Bio、Annuouda、Beijing Wantai、Haixi Bio、Qiagen、Abbott、Kanglu Biotechnology、Guangzhou Anbiping

地域別市場区分、地域別分析は以下の通り:
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント:
PCR
FISH
DNA Sequencing
Gene Chip

用途別の市場セグメント:
Clinical Diagnosis
Drug Screening
Research

レポートの詳細内容
世界の白血病簡易診断市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、白血病簡易診断タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の白血病簡易診断収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の白血病簡易診断市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、白血病簡易診断市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

白血病簡易診断のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
1章:白血病簡易診断のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント(製品タイプ、用途など)のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。(20192030
2章:白血病簡易診断の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。(20192030
3白血病簡易診断企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。(20192030
4章:各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。(20192024
5章:白血病簡易診断の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。(20192030
6章:北米(米国、カナダ)のタイプ別、アプリケーション別、国別、各セグメントの収益。(20192030
7章:ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。(20192030
8章:中国の種類別、および用途別、各セグメントの収益。(20192030
9章アジア(中国を除く)の種類別、用途別、地域別、セグメントごとの収益。(20192030
10章:中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。(20192030
11章:白血病簡易診断の主要企業の概要を提供し、製品の説明と仕様、白血病簡易診断の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。(20192024
12章:アナリストの見解/結論

biaoTi

概要

Molecular diagnosis of leukemia is a method of diagnosing and classifying leukemia by detecting specific gene mutations, chromosomal abnormalities or other molecular markers in leukemia patients. This diagnostic technology uses advanced molecular biology tools such as PCR (polymerase chain reaction), gene sequencing and fluorescence in situ hybridization (FISH) to identify molecular features in leukemia cells. Molecular diagnosis of leukemia not only helps to diagnose the disease, but also can accurately classify leukemia subtypes, providing an important basis for the formulation of individualized treatment plans. This precise diagnostic method helps to assess the patient's prognosis, monitor the effectiveness of treatment, and detect the risk of recurrence at an early stage. It is an indispensable tool in modern leukemia management.
The global Leukemia Molecular Diagnostics market is projected to grow from US$ 2115 million in 2024 to US$ 3819 million by 2030, at a Compound Annual Growth Rate (CAGR) of 10.4% during the forecast period.
The increasing adoption of personalized medicine is a key driver for the leukemia molecular diagnostics market. Advances in molecular diagnostic technologies, such as next-generation sequencing (NGS) and polymerase chain reaction (PCR), enable precise genetic profiling of leukemia, leading to more targeted and effective treatment plans. This personalized approach not only improves patient outcomes but also boosts demand for molecular diagnostics in leukemia management.
One of the main challenges in the leukemia molecular diagnostics market is the high cost associated with advanced diagnostic tools and testing procedures. These technologies often require significant investment in equipment, skilled personnel, and infrastructure, which can limit accessibility in low-resource settings, reducing the potential reach of molecular diagnostics in leukemia care.
Report Includes
This report presents an overview of global market for Leukemia Molecular Diagnostics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Leukemia Molecular Diagnostics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Leukemia Molecular Diagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Leukemia Molecular Diagnostics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Leukemia Molecular Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Leukemia Molecular Diagnostics revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Ruiang Gene, Zhishan Bio, Zhijiang Bio, Jinpujia Medical, Merle Bio, Herui Gene, Aicon Bio, Annuouda, Beijing Wantai, Haixi Bio, etc.

Market Segmentation
By Company
    Ruiang Gene
    Zhishan Bio
    Zhijiang Bio
    Jinpujia Medical
    Merle Bio
    Herui Gene
    Aicon Bio
    Annuouda
    Beijing Wantai
    Haixi Bio
    Qiagen
    Abbott
    Kanglu Biotechnology
    Guangzhou Anbiping

Segment by Type
    PCR
    FISH
    DNA Sequencing
    Gene Chip

Segment by Application
    Clinical Diagnosis
    Drug Screening
    Research

By Region
    North America
        United States
        Canada
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    Latin America
        Mexico
        Brazil
        Rest of South America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Leukemia Molecular Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Leukemia Molecular Diagnostics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Leukemia Molecular Diagnostics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
biaoTi

総目録

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Leukemia Molecular Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 PCR
1.2.3 FISH
1.2.4 DNA Sequencing
1.2.5 Gene Chip
1.3 Market by Application
1.3.1 Global Leukemia Molecular Diagnostics Market Share by Application: 2019 VS 2023 VS 2030
1.3.2 Clinical Diagnosis
1.3.3 Drug Screening
1.3.4 Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Leukemia Molecular Diagnostics Market Perspective (2019-2030)
2.2 Global Leukemia Molecular Diagnostics Growth Trends by Region
2.2.1 Global Leukemia Molecular Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Leukemia Molecular Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Leukemia Molecular Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Leukemia Molecular Diagnostics Market Dynamics
2.3.1 Leukemia Molecular Diagnostics Industry Trends
2.3.2 Leukemia Molecular Diagnostics Market Drivers
2.3.3 Leukemia Molecular Diagnostics Market Challenges
2.3.4 Leukemia Molecular Diagnostics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Revenue Leukemia Molecular Diagnostics by Players
3.1.1 Global Leukemia Molecular Diagnostics Revenue by Players (2019-2024)
3.1.2 Global Leukemia Molecular Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Leukemia Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Leukemia Molecular Diagnostics, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Leukemia Molecular Diagnostics Market Concentration Ratio
3.4.1 Global Leukemia Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Leukemia Molecular Diagnostics Revenue in 2023
3.5 Global Key Players of Leukemia Molecular Diagnostics Head office and Area Served
3.6 Global Key Players of Leukemia Molecular Diagnostics, Product and Application
3.7 Global Key Players of Leukemia Molecular Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans

4 Leukemia Molecular Diagnostics Breakdown Data by Type
4.1 Global Leukemia Molecular Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Leukemia Molecular Diagnostics Forecasted Market Size by Type (2025-2030)

5 Leukemia Molecular Diagnostics Breakdown Data by Application
5.1 Global Leukemia Molecular Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Leukemia Molecular Diagnostics Forecasted Market Size by Application (2025-2030)

6 North America
6.1 North America Leukemia Molecular Diagnostics Market Size (2019-2030)
6.2 North America Leukemia Molecular Diagnostics Market Size by Type
6.2.1 North America Leukemia Molecular Diagnostics Market Size by Type (2019-2024)
6.2.2 North America Leukemia Molecular Diagnostics Market Size by Type (2025-2030)
6.2.3 North America Leukemia Molecular Diagnostics Market Share by Type (2019-2030)
6.3 North America Leukemia Molecular Diagnostics Market Size by Application
6.3.1 North America Leukemia Molecular Diagnostics Market Size by Application (2019-2024)
6.3.2 North America Leukemia Molecular Diagnostics Market Size by Application (2025-2030)
6.3.3 North America Leukemia Molecular Diagnostics Market Share by Application (2019-2030)
6.4 North America Leukemia Molecular Diagnostics Market Size by Country
6.4.1 North America Leukemia Molecular Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Leukemia Molecular Diagnostics Market Size by Country (2019-2024)
6.4.3 North America Leukemia Molecular Diagnostics Market Share by Country (2025-2030)
6.4.4 United States
6.4.5 Canada

7 Europe
7.1 Europe Leukemia Molecular Diagnostics Market Size (2019-2030)
7.2 Europe Leukemia Molecular Diagnostics Market Size by Type
7.2.1 Europe Leukemia Molecular Diagnostics Market Size by Type (2019-2024)
7.2.2 Europe Leukemia Molecular Diagnostics Market Size by Type (2025-2030)
7.2.3 Europe Leukemia Molecular Diagnostics Market Share by Type (2019-2030)
7.3 Europe Leukemia Molecular Diagnostics Market Size by Application
7.3.1 Europe Leukemia Molecular Diagnostics Market Size by Application (2019-2024)
7.3.2 Europe Leukemia Molecular Diagnostics Market Size by Application (2025-2030)
7.3.3 Europe Leukemia Molecular Diagnostics Market Share by Application (2019-2030)
7.4 Europe Leukemia Molecular Diagnostics Market Size by Country
7.4.1 Europe Leukemia Molecular Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Leukemia Molecular Diagnostics Market Size by Country (2019-2024)
7.4.3 Europe Leukemia Molecular Diagnostics Market Size by Country (2025-2030)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
7.4.9 Nordic Countries

8 China
8.1 China Leukemia Molecular Diagnostics Market Size (2019-2030)
8.2 China Leukemia Molecular Diagnostics Market Size by Type
8.2.1 China Leukemia Molecular Diagnostics Market Size by Type (2019-2024)
8.2.2 China Leukemia Molecular Diagnostics Market Size by Type (2025-2030)
8.2.3 China Leukemia Molecular Diagnostics Market Share by Type (2019-2030)
8.3 China Leukemia Molecular Diagnostics Market Size by Application
8.3.1 China Leukemia Molecular Diagnostics Market Size by Application (2019-2024)
8.3.2 China Leukemia Molecular Diagnostics Market Size by Application (2025-2030)
8.3.3 China Leukemia Molecular Diagnostics Market Share by Application (2019-2030)

9 Asia (excluding China)
9.1 Asia Leukemia Molecular Diagnostics Market Size (2019-2030)
9.2 Asia Leukemia Molecular Diagnostics Market Size by Type
9.2.1 Asia Leukemia Molecular Diagnostics Market Size by Type (2019-2024)
9.2.2 Asia Leukemia Molecular Diagnostics Market Size by Type (2025-2030)
9.2.3 Asia Leukemia Molecular Diagnostics Market Share by Type (2019-2030)
9.3 Asia Leukemia Molecular Diagnostics Market Size by Application
9.3.1 Asia Leukemia Molecular Diagnostics Market Size by Application (2019-2024)
9.3.2 Asia Leukemia Molecular Diagnostics Market Size by Application (2025-2030)
9.3.3 Asia Leukemia Molecular Diagnostics Market Share by Application (2019-2030)
9.4 Asia Leukemia Molecular Diagnostics Market Size by Region
9.4.1 Asia Leukemia Molecular Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Leukemia Molecular Diagnostics Market Size by Region (2019-2024)
9.4.3 Asia Leukemia Molecular Diagnostics Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia

10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Leukemia Molecular Diagnostics Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Leukemia Molecular Diagnostics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Leukemia Molecular Diagnostics Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Leukemia Molecular Diagnostics Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Leukemia Molecular Diagnostics Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Leukemia Molecular Diagnostics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Leukemia Molecular Diagnostics Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Leukemia Molecular Diagnostics Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Leukemia Molecular Diagnostics Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Leukemia Molecular Diagnostics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Leukemia Molecular Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Leukemia Molecular Diagnostics Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Leukemia Molecular Diagnostics Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries

11 Key Players Profiles
11.1 Ruiang Gene
11.1.1 Ruiang Gene Company Details
11.1.2 Ruiang Gene Business Overview
11.1.3 Ruiang Gene Leukemia Molecular Diagnostics Introduction
11.1.4 Ruiang Gene Revenue in Leukemia Molecular Diagnostics Business (2019-2024)
11.1.5 Ruiang Gene Recent Development
11.2 Zhishan Bio
11.2.1 Zhishan Bio Company Details
11.2.2 Zhishan Bio Business Overview
11.2.3 Zhishan Bio Leukemia Molecular Diagnostics Introduction
11.2.4 Zhishan Bio Revenue in Leukemia Molecular Diagnostics Business (2019-2024)
11.2.5 Zhishan Bio Recent Development
11.3 Zhijiang Bio
11.3.1 Zhijiang Bio Company Details
11.3.2 Zhijiang Bio Business Overview
11.3.3 Zhijiang Bio Leukemia Molecular Diagnostics Introduction
11.3.4 Zhijiang Bio Revenue in Leukemia Molecular Diagnostics Business (2019-2024)
11.3.5 Zhijiang Bio Recent Development
11.4 Jinpujia Medical
11.4.1 Jinpujia Medical Company Details
11.4.2 Jinpujia Medical Business Overview
11.4.3 Jinpujia Medical Leukemia Molecular Diagnostics Introduction
11.4.4 Jinpujia Medical Revenue in Leukemia Molecular Diagnostics Business (2019-2024)
11.4.5 Jinpujia Medical Recent Development
11.5 Merle Bio
11.5.1 Merle Bio Company Details
11.5.2 Merle Bio Business Overview
11.5.3 Merle Bio Leukemia Molecular Diagnostics Introduction
11.5.4 Merle Bio Revenue in Leukemia Molecular Diagnostics Business (2019-2024)
11.5.5 Merle Bio Recent Development
11.6 Herui Gene
11.6.1 Herui Gene Company Details
11.6.2 Herui Gene Business Overview
11.6.3 Herui Gene Leukemia Molecular Diagnostics Introduction
11.6.4 Herui Gene Revenue in Leukemia Molecular Diagnostics Business (2019-2024)
11.6.5 Herui Gene Recent Development
11.7 Aicon Bio
11.7.1 Aicon Bio Company Details
11.7.2 Aicon Bio Business Overview
11.7.3 Aicon Bio Leukemia Molecular Diagnostics Introduction
11.7.4 Aicon Bio Revenue in Leukemia Molecular Diagnostics Business (2019-2024)
11.7.5 Aicon Bio Recent Development
11.8 Annuouda
11.8.1 Annuouda Company Details
11.8.2 Annuouda Business Overview
11.8.3 Annuouda Leukemia Molecular Diagnostics Introduction
11.8.4 Annuouda Revenue in Leukemia Molecular Diagnostics Business (2019-2024)
11.8.5 Annuouda Recent Development
11.9 Beijing Wantai
11.9.1 Beijing Wantai Company Details
11.9.2 Beijing Wantai Business Overview
11.9.3 Beijing Wantai Leukemia Molecular Diagnostics Introduction
11.9.4 Beijing Wantai Revenue in Leukemia Molecular Diagnostics Business (2019-2024)
11.9.5 Beijing Wantai Recent Development
11.10 Haixi Bio
11.10.1 Haixi Bio Company Details
11.10.2 Haixi Bio Business Overview
11.10.3 Haixi Bio Leukemia Molecular Diagnostics Introduction
11.10.4 Haixi Bio Revenue in Leukemia Molecular Diagnostics Business (2019-2024)
11.10.5 Haixi Bio Recent Development
11.11 Qiagen
11.11.1 Qiagen Company Details
11.11.2 Qiagen Business Overview
11.11.3 Qiagen Leukemia Molecular Diagnostics Introduction
11.11.4 Qiagen Revenue in Leukemia Molecular Diagnostics Business (2019-2024)
11.11.5 Qiagen Recent Development
11.12 Abbott
11.12.1 Abbott Company Details
11.12.2 Abbott Business Overview
11.12.3 Abbott Leukemia Molecular Diagnostics Introduction
11.12.4 Abbott Revenue in Leukemia Molecular Diagnostics Business (2019-2024)
11.12.5 Abbott Recent Development
11.13 Kanglu Biotechnology
11.13.1 Kanglu Biotechnology Company Details
11.13.2 Kanglu Biotechnology Business Overview
11.13.3 Kanglu Biotechnology Leukemia Molecular Diagnostics Introduction
11.13.4 Kanglu Biotechnology Revenue in Leukemia Molecular Diagnostics Business (2019-2024)
11.13.5 Kanglu Biotechnology Recent Development
11.14 Guangzhou Anbiping
11.14.1 Guangzhou Anbiping Company Details
11.14.2 Guangzhou Anbiping Business Overview
11.14.3 Guangzhou Anbiping Leukemia Molecular Diagnostics Introduction
11.14.4 Guangzhou Anbiping Revenue in Leukemia Molecular Diagnostics Business (2019-2024)
11.14.5 Guangzhou Anbiping Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

biaoTi

表と図のリスト

List of Tables
 Table 1. Global Leukemia Molecular Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of PCR
 Table 3. Key Players of FISH
 Table 4. Key Players of DNA Sequencing
 Table 5. Key Players of Gene Chip
 Table 6. Global Leukemia Molecular Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 7. Global Leukemia Molecular Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 8. Global Leukemia Molecular Diagnostics Market Size by Region (2019-2024) & (US$ Million)
 Table 9. Global Leukemia Molecular Diagnostics Market Share by Region (2019-2024)
 Table 10. Global Leukemia Molecular Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 11. Global Leukemia Molecular Diagnostics Market Share by Region (2025-2030)
 Table 12. Leukemia Molecular Diagnostics Market Trends
 Table 13. Leukemia Molecular Diagnostics Market Drivers
 Table 14. Leukemia Molecular Diagnostics Market Challenges
 Table 15. Leukemia Molecular Diagnostics Market Restraints
 Table 16. Global Leukemia Molecular Diagnostics Revenue by Players (2019-2024) & (US$ Million)
 Table 17. Global Leukemia Molecular Diagnostics Market Share by Players (2019-2024)
 Table 18. Global Top Leukemia Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leukemia Molecular Diagnostics as of 2023)
 Table 19. Global Leukemia Molecular Diagnostics Industry Ranking 2022 VS 2023
 Table 20. Global 5 Largest Players Market Share by Leukemia Molecular Diagnostics Revenue (CR5 and HHI) & (2019-2024)
 Table 21. Global Key Players of Leukemia Molecular Diagnostics, Headquarters and Area Served
 Table 22. Global Key Players of Leukemia Molecular Diagnostics, Product and Application
 Table 23. Global Key Players of Leukemia Molecular Diagnostics, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Leukemia Molecular Diagnostics Market Size by Type (2019-2024) & (US$ Million)
 Table 26. Global Leukemia Molecular Diagnostics Revenue Market Share by Type (2019-2024)
 Table 27. Global Leukemia Molecular Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 28. Global Leukemia Molecular Diagnostics Revenue Market Share by Type (2025-2030)
 Table 29. Global Leukemia Molecular Diagnostics Market Size by Application (2019-2024) & (US$ Million)
 Table 30. Global Leukemia Molecular Diagnostics Revenue Market Share by Application (2019-2024)
 Table 31. Global Leukemia Molecular Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 32. Global Leukemia Molecular Diagnostics Revenue Market Share by Application (2025-2030)
 Table 33. North America Leukemia Molecular Diagnostics Market Size by Type (2019-2024) & (US$ Million)
 Table 34. North America Leukemia Molecular Diagnostics Market Size by Type (2025-2030) & (US$ Million)
 Table 35. North America Leukemia Molecular Diagnostics Market Size by Application (2019-2024) & (US$ Million)
 Table 36. North America Leukemia Molecular Diagnostics Market Size by Application (2025-2030) & (US$ Million)
 Table 37. North America Leukemia Molecular Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 38. North America Leukemia Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)
 Table 39. North America Leukemia Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)
 Table 40. Europe Leukemia Molecular Diagnostics Market Size by Type (2019-2024) & (US$ Million)
 Table 41. Europe Leukemia Molecular Diagnostics Market Size by Type (2025-2030) & (US$ Million)
 Table 42. Europe Leukemia Molecular Diagnostics Market Size by Application (2019-2024) & (US$ Million)
 Table 43. Europe Leukemia Molecular Diagnostics Market Size by Application (2025-2030) & (US$ Million)
 Table 44. Europe Leukemia Molecular Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 45. Europe Leukemia Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)
 Table 46. Europe Leukemia Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)
 Table 47. China Leukemia Molecular Diagnostics Market Size by Type (2019-2024) & (US$ Million)
 Table 48. China Leukemia Molecular Diagnostics Market Size by Type (2025-2030) & (US$ Million)
 Table 49. China Leukemia Molecular Diagnostics Market Size by Application (2019-2024) & (US$ Million)
 Table 50. China Leukemia Molecular Diagnostics Market Size by Application (2025-2030) & (US$ Million)
 Table 51. Asia Leukemia Molecular Diagnostics Market Size by Type (2019-2024) & (US$ Million)
 Table 52. Asia Leukemia Molecular Diagnostics Market Size by Type (2025-2030) & (US$ Million)
 Table 53. Asia Leukemia Molecular Diagnostics Market Size by Application (2019-2024) & (US$ Million)
 Table 54. Asia Leukemia Molecular Diagnostics Market Size by Application (2025-2030) & (US$ Million)
 Table 55. Asia Leukemia Molecular Diagnostics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 56. Asia Leukemia Molecular Diagnostics Market Size by Region (2019-2024) & (US$ Million)
 Table 57. Asia Leukemia Molecular Diagnostics Market Size by Region (2025-2030) & (US$ Million)
 Table 58. Middle East, Africa, and Latin America Leukemia Molecular Diagnostics Market Size by Type (2019-2024) & (US$ Million)
 Table 59. Middle East, Africa, and Latin America Leukemia Molecular Diagnostics Market Size by Type (2025-2030) & (US$ Million)
 Table 60. Middle East, Africa, and Latin America Leukemia Molecular Diagnostics Market Size by Application (2019-2024) & (US$ Million)
 Table 61. Middle East, Africa, and Latin America Leukemia Molecular Diagnostics Market Size by Application (2025-2030) & (US$ Million)
 Table 62. Middle East, Africa, and Latin America Leukemia Molecular Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 63. Middle East, Africa, and Latin America Leukemia Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)
 Table 64. Middle East, Africa, and Latin America Leukemia Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)
 Table 65. Ruiang Gene Company Details
 Table 66. Ruiang Gene Business Overview
 Table 67. Ruiang Gene Leukemia Molecular Diagnostics Product
 Table 68. Ruiang Gene Revenue in Leukemia Molecular Diagnostics Business (2019-2024) & (US$ Million)
 Table 69. Ruiang Gene Recent Development
 Table 70. Zhishan Bio Company Details
 Table 71. Zhishan Bio Business Overview
 Table 72. Zhishan Bio Leukemia Molecular Diagnostics Product
 Table 73. Zhishan Bio Revenue in Leukemia Molecular Diagnostics Business (2019-2024) & (US$ Million)
 Table 74. Zhishan Bio Recent Development
 Table 75. Zhijiang Bio Company Details
 Table 76. Zhijiang Bio Business Overview
 Table 77. Zhijiang Bio Leukemia Molecular Diagnostics Product
 Table 78. Zhijiang Bio Revenue in Leukemia Molecular Diagnostics Business (2019-2024) & (US$ Million)
 Table 79. Zhijiang Bio Recent Development
 Table 80. Jinpujia Medical Company Details
 Table 81. Jinpujia Medical Business Overview
 Table 82. Jinpujia Medical Leukemia Molecular Diagnostics Product
 Table 83. Jinpujia Medical Revenue in Leukemia Molecular Diagnostics Business (2019-2024) & (US$ Million)
 Table 84. Jinpujia Medical Recent Development
 Table 85. Merle Bio Company Details
 Table 86. Merle Bio Business Overview
 Table 87. Merle Bio Leukemia Molecular Diagnostics Product
 Table 88. Merle Bio Revenue in Leukemia Molecular Diagnostics Business (2019-2024) & (US$ Million)
 Table 89. Merle Bio Recent Development
 Table 90. Herui Gene Company Details
 Table 91. Herui Gene Business Overview
 Table 92. Herui Gene Leukemia Molecular Diagnostics Product
 Table 93. Herui Gene Revenue in Leukemia Molecular Diagnostics Business (2019-2024) & (US$ Million)
 Table 94. Herui Gene Recent Development
 Table 95. Aicon Bio Company Details
 Table 96. Aicon Bio Business Overview
 Table 97. Aicon Bio Leukemia Molecular Diagnostics Product
 Table 98. Aicon Bio Revenue in Leukemia Molecular Diagnostics Business (2019-2024) & (US$ Million)
 Table 99. Aicon Bio Recent Development
 Table 100. Annuouda Company Details
 Table 101. Annuouda Business Overview
 Table 102. Annuouda Leukemia Molecular Diagnostics Product
 Table 103. Annuouda Revenue in Leukemia Molecular Diagnostics Business (2019-2024) & (US$ Million)
 Table 104. Annuouda Recent Development
 Table 105. Beijing Wantai Company Details
 Table 106. Beijing Wantai Business Overview
 Table 107. Beijing Wantai Leukemia Molecular Diagnostics Product
 Table 108. Beijing Wantai Revenue in Leukemia Molecular Diagnostics Business (2019-2024) & (US$ Million)
 Table 109. Beijing Wantai Recent Development
 Table 110. Haixi Bio Company Details
 Table 111. Haixi Bio Business Overview
 Table 112. Haixi Bio Leukemia Molecular Diagnostics Product
 Table 113. Haixi Bio Revenue in Leukemia Molecular Diagnostics Business (2019-2024) & (US$ Million)
 Table 114. Haixi Bio Recent Development
 Table 115. Qiagen Company Details
 Table 116. Qiagen Business Overview
 Table 117. Qiagen Leukemia Molecular Diagnostics Product
 Table 118. Qiagen Revenue in Leukemia Molecular Diagnostics Business (2019-2024) & (US$ Million)
 Table 119. Qiagen Recent Development
 Table 120. Abbott Company Details
 Table 121. Abbott Business Overview
 Table 122. Abbott Leukemia Molecular Diagnostics Product
 Table 123. Abbott Revenue in Leukemia Molecular Diagnostics Business (2019-2024) & (US$ Million)
 Table 124. Abbott Recent Development
 Table 125. Kanglu Biotechnology Company Details
 Table 126. Kanglu Biotechnology Business Overview
 Table 127. Kanglu Biotechnology Leukemia Molecular Diagnostics Product
 Table 128. Kanglu Biotechnology Revenue in Leukemia Molecular Diagnostics Business (2019-2024) & (US$ Million)
 Table 129. Kanglu Biotechnology Recent Development
 Table 130. Guangzhou Anbiping Company Details
 Table 131. Guangzhou Anbiping Business Overview
 Table 132. Guangzhou Anbiping Leukemia Molecular Diagnostics Product
 Table 133. Guangzhou Anbiping Revenue in Leukemia Molecular Diagnostics Business (2019-2024) & (US$ Million)
 Table 134. Guangzhou Anbiping Recent Development
 Table 135. Research Programs/Design for This Report
 Table 136. Key Data Information from Secondary Sources
 Table 137. Key Data Information from Primary Sources


List of Figures
 Figure 1. Global Leukemia Molecular Diagnostics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 2. Global Leukemia Molecular Diagnostics Market Share by Type: 2023 VS 2030
 Figure 3. PCR Features
 Figure 4. FISH Features
 Figure 5. DNA Sequencing Features
 Figure 6. Gene Chip Features
 Figure 7. Global Leukemia Molecular Diagnostics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 8. Global Leukemia Molecular Diagnostics Market Share by Application: 2023 VS 2030
 Figure 9. Clinical Diagnosis Case Studies
 Figure 10. Drug Screening Case Studies
 Figure 11. Research Case Studies
 Figure 12. Leukemia Molecular Diagnostics Report Years Considered
 Figure 13. Global Leukemia Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 14. Global Leukemia Molecular Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 15. Global Leukemia Molecular Diagnostics Market Share by Region: 2023 VS 2030
 Figure 16. Global Leukemia Molecular Diagnostics Market Share by Players in 2023
 Figure 17. Global Top Leukemia Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leukemia Molecular Diagnostics as of 2023)
 Figure 18. The Top 10 and 5 Players Market Share by Leukemia Molecular Diagnostics Revenue in 2023
 Figure 19. North America Leukemia Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 20. North America Leukemia Molecular Diagnostics Market Share by Type (2019-2030)
 Figure 21. North America Leukemia Molecular Diagnostics Market Share by Application (2019-2030)
 Figure 22. North America Leukemia Molecular Diagnostics Market Share by Country (2019-2030)
 Figure 23. United States Leukemia Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 24. Canada Leukemia Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 25. Europe Leukemia Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 26. Europe Leukemia Molecular Diagnostics Market Share by Type (2019-2030)
 Figure 27. Europe Leukemia Molecular Diagnostics Market Share by Application (2019-2030)
 Figure 28. Europe Leukemia Molecular Diagnostics Market Share by Country (2019-2030)
 Figure 29. Germany Leukemia Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. France Leukemia Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. U.K. Leukemia Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. Italy Leukemia Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. Russia Leukemia Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 34. Nordic Countries Leukemia Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. China Leukemia Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. China Leukemia Molecular Diagnostics Market Share by Type (2019-2030)
 Figure 37. China Leukemia Molecular Diagnostics Market Share by Application (2019-2030)
 Figure 38. Asia Leukemia Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. Asia Leukemia Molecular Diagnostics Market Share by Type (2019-2030)
 Figure 40. Asia Leukemia Molecular Diagnostics Market Share by Application (2019-2030)
 Figure 41. Asia Leukemia Molecular Diagnostics Market Share by Region (2019-2030)
 Figure 42. Japan Leukemia Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. South Korea Leukemia Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. China Taiwan Leukemia Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. Southeast Asia Leukemia Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. India Leukemia Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. Australia Leukemia Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 48. Middle East, Africa, and Latin America Leukemia Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 49. Middle East, Africa, and Latin America Leukemia Molecular Diagnostics Market Share by Type (2019-2030)
 Figure 50. Middle East, Africa, and Latin America Leukemia Molecular Diagnostics Market Share by Application (2019-2030)
 Figure 51. Middle East, Africa, and Latin America Leukemia Molecular Diagnostics Market Share by Country (2019-2030)
 Figure 52. Brazil Leukemia Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 53. Mexico Leukemia Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 54. Turkey Leukemia Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 55. Saudi Arabia Leukemia Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 56. Israel Leukemia Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 57. GCC Countries Leukemia Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 58. Ruiang Gene Revenue Growth Rate in Leukemia Molecular Diagnostics Business (2019-2024)
 Figure 59. Zhishan Bio Revenue Growth Rate in Leukemia Molecular Diagnostics Business (2019-2024)
 Figure 60. Zhijiang Bio Revenue Growth Rate in Leukemia Molecular Diagnostics Business (2019-2024)
 Figure 61. Jinpujia Medical Revenue Growth Rate in Leukemia Molecular Diagnostics Business (2019-2024)
 Figure 62. Merle Bio Revenue Growth Rate in Leukemia Molecular Diagnostics Business (2019-2024)
 Figure 63. Herui Gene Revenue Growth Rate in Leukemia Molecular Diagnostics Business (2019-2024)
 Figure 64. Aicon Bio Revenue Growth Rate in Leukemia Molecular Diagnostics Business (2019-2024)
 Figure 65. Annuouda Revenue Growth Rate in Leukemia Molecular Diagnostics Business (2019-2024)
 Figure 66. Beijing Wantai Revenue Growth Rate in Leukemia Molecular Diagnostics Business (2019-2024)
 Figure 67. Haixi Bio Revenue Growth Rate in Leukemia Molecular Diagnostics Business (2019-2024)
 Figure 68. Qiagen Revenue Growth Rate in Leukemia Molecular Diagnostics Business (2019-2024)
 Figure 69. Abbott Revenue Growth Rate in Leukemia Molecular Diagnostics Business (2019-2024)
 Figure 70. Kanglu Biotechnology Revenue Growth Rate in Leukemia Molecular Diagnostics Business (2019-2024)
 Figure 71. Guangzhou Anbiping Revenue Growth Rate in Leukemia Molecular Diagnostics Business (2019-2024)
 Figure 72. Bottom-up and Top-down Approaches for This Report
 Figure 73. Data Triangulation
 Figure 74. Key Executives Interviewed
当社から購入のメリット
サンプル提供

01. サンプル提供

ご購入前にサンプル(英語、日本語)が提供可能。

カスタマイズサービス

02. カスタマイズサービス

レポートの一部をご購入可能;基本バージョンに加え、ご要望に応じたカスタム委託調査も提供可能。

プロフェッショナルな日本語翻訳

03. プロフェッショナルな日本語翻訳

AI翻訳ではなく、プロフェッショナルな日本語翻訳をご提供。納期:英語は2-4営業日以内、日本語は8-10営業日以内。

多言語コミュニケーション

04. 多言語コミュニケーション

日本語、英語、中国語、ヒンディー語、ドイツ語、韓国語、フランス語の7ヶ国語でコミュニケーションサービスをご提供。

 お支払方法

05. お支払方法

銀行振込(納品後、ご請求書送付)。

アフターサービス

06. アフターサービス

ご購入後、ご質問があれば、3ヵ月以内に無料でアナリストと直接的に連絡できる。

ご注文方法

請求書払いの場合:

  • yuan01

    レポート選択

  • yuan01

    見積もり依頼

  • yuan01

    メールでのご注文

  • yuan01

    入手(英語版は2〜4営業日、日本語版は8〜10営業日)

  • yuan01

    決済(後払い)

クレジットカード決済の場合:

  • yuan01

    レポート選択

  • yuan01

    ウェブサイトでのご注文

  • yuan01

    決済

  • yuan01

    入手(英語版は2〜4営業日、日本語版は8〜10営業日)